|
Real-time Estimate
Cboe BZX
19:02:00 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 18.71 USD | -1.68% |
|
-3.53% | -29.75% |
| 09-01 | Top Midday Decliners | MT |
| 09-01 | BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Devices & Implants
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.1B | |||||
| 106B | |||||
| 11.68B | |||||
| 10.6B | - | ||||
| 4.08B | |||||
| 2.42B | - | - | - | - |
- Stock Market
- Stocks
- ENOV Stock
- Charts Enovis Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
